Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Warning To Consumers About Recreational Use Of Medicines, Australia
The National Prescribing Service (NPS) warns people are playing Russian roulette with their health when they take medicines inappropriately. Media reports this week about people mixing sleeping tablet, zolpidem (Stilnox), with energy drink Red Bull™ have failed to highlight the risks people are taking when they intentionally misuse pharmaceuticals.
generic viagra online
Summit To Shape Future Dementia Research
An initiative from the Government"s National Dementia Strategy, the summit will examine research into cause, cure and care, highlighting gaps in knowledge and new opportunities for the future. A report will then be produced to help shape the future dementia research agenda.
News of the day
New NHS Focus On Audiology Brings Faster Hearing Aid Treatment
A determined effort by Audiology teams across the country has led to 99% of people receiving hearing aids or other appropriate treatment within the government"s 18-week target. Figures for February 2009, just released by the Department of Health, show that the situation has been improving every month since April 2008. The improvements have come about as a result of re-instating frozen posts combined with a determined effort by Audiology teams to work in more flexible and creative ways.
Sexual Health

$5 Million Gift Funds New Cancer Research Initiative

The Keck School of Medicine of the University of Southern California (USC) today announced a $5 million gift from the Ellison Medical Foundation to support cancer research under the direction of David B. Agus, M.D., a renowned oncologist and cancer researcher who joined the Keck School faculty on April 1 as a professor of medicine. Agus will serve as principal investigator for the project entitled "Molecular Technologies in Cancer." The initiative will focus on molecularly targeted therapy, which holds promise as a new paradigm for cancer treatment. "The generous gift from the Ellison Medical Foundation will allow the initiation of this exciting program and advance the clinical translational work at USC," says Keck School of Medicine Dean Carmen A. Puliafito. "Dr. Agus is an outstanding choice to lead this project, which we believe will make a significant impact on cancer treatment in potentially revolutionary ways." The Ellison Medical Foundation is a non-profit organization founded by Lawrence J. Ellison, an entrepreneur and CEO of Oracle Corporation. The foundation is dedicated to supporting new, creative research that might not be funded by traditional s. "It is my pleasure to work with Dr. Agus and his research associates in developing new technologies to help patients with cancer," Ellison says. "I believe his unique approach to medical oncology will help better control many of the diseases impacting mankind today." Agus" research in proteomic technology seeks to integrate clinical trials, pre-clinical studies and molecularly targeted therapy-which focuses on molecular and cellular changes that are specific to cancer-to predict which patients will likely respond to a specific anti-cancer therapy. He will lead a team of researchers at the USC Center for Applied Molecular Medicine at the Keck School of Medicine. "My team and I are so honored and excited to team with the Ellison Medical Foundation to begin these new programs at USC to help bring new technologies and high quality care to patients with cancer," he says. In addition, Dr. Agus will direct the new USC Westside Prostate Cancer Center, a multi-disciplinary center that is focused on cutting edge care for patients with prostate cancer. The center is located at 8900 Wilshire Boulevard in Beverly Hills. Prior to joining the Keck School of Medicine, Agus served as the Director of the Spielberg Family Center for Applied Proteomics and Research Director of the Louis Warschaw Prostate Cancer Center at Cedars-Sinai Medical Center. He and his research team have focused on factors influencing the development and progression of cancer. In the laboratory, Agus conducts research focused on understanding the biology of cancer and the development of new drugs and treatments for cancer. He also uses new technologies, in the field of proteomics and nanotechnology-that reveal valuable information regarding "on" and "off" switches of the cancer and ultimately a more complete understanding of the various factors that influence cancer development, progression and response to treatment. Agus has published numerous articles and received several awards in the fields of cancer research and drug development. Dr. Agus graduated cum laude with honors in molecular biology from Princeton University, and received his medical degree from the University of Pennsylvania School of Medicine. He completed his medical internship and residency training at Johns Hopkins Hospital, and fellowship at Memorial Sloan-Kettering Cancer Center. University of Southern California

singapore florist commented:

a best guide on gifts topic. Going for this information is quite simple

14.05.2012


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009